OVERVIEW

8th Drug-Device Combination Products is organized by Vonlanthen Group of Companies and will be held from Sep 23 - 24, 2026 in Amsterdam, Noord Holland, Netherlands.

Key Practical Learning Points:

Design for Success – Integrate Quality by Design (QbD) with robust design controls to ensure device compatibility, efficiency, and patient safety.
Early Development Strategies – Optimize processes through early device specifications and material compatibility assessments to reduce risk and streamline regulatory pathways.
Regulatory Readiness – Navigate evolving EU MDR requirements and anticipate future regulations to ensure smooth market access.
Performance & Safety Excellence – Define clear performance metrics, apply rigorous design verification, and leverage advanced risk management techniques.
Sustainability & Innovation – Implement technology-driven solutions to minimize environmental impact, including connected devices and wearable injectors.
Cross-Functional Collaboration – Foster seamless teamwork between pharmaceutical and device teams to accelerate innovation and enhance patient outcomes.